Research in the News2020-09-07T14:49:15+00:00

Research in the News

DOR researchers are recognized internationally for their scientific expertise and have contributed more than 3,000 scientific papers about how to use health informatics, manage chronic illness, and motivate self-care and disease prevention.

New Kaiser Permanente Study: Both Components of Blood Pressure Important for Heart Health

Both systolic and diastolic blood pressures independently predicted the risk of heart attack or stroke in a large Kaiser Permanente Northern California study that included more than 36 million blood pressure readings from over 1 million people.

“Catch-up” HPV Vaccination Works for Females up to Age 20 Years at First Dose, Not Older Ages

Kaiser Permanente study confirms recommendations for catch-up HPV vaccination with three doses in females aged 15 to 20, but not when started at or after age 21.

30-Year National Study Shows Women Who Breastfeed for 6 Months or More Reduce their Diabetes Risk by 50%

Erica Gunderson, PhD, MS, MPH, discusses findings in a 30-year study that show the protective effects of breastfeeding for both mothers and their offspring, including lowering a mother’s risk of developing diabetes, breast and ovarian cancer.

New Kaiser Permanente Study Reveals an Increase in Marijuana Use During Pregnancy

Kelly Young-Wolff, PhD, KP Division of Research, and Nancy Goler, MD, discuss their study addressing the increase in maternal prenatal marijuana use, and how the results fill a critical data gap in understanding marijuana use among pregnant women.

Urban American-Indian and Alaskan Natives May Have Lower Survival Following Invasive Prostate and Breast Cancer

Laurel A. Habel, PhD discusses research from TPMG's Division of Research that finds urban American-Indian and Alaskan Native communities are more likely to have lower survival rates following invasive prostate and breast cancer.

Indivior’s Experimental Drug to Fight Opioid Addiction is Approved by the US FDA

Laurel Habel, Ph.D, from TPMG's Division of Research, describes Indivior as a promising alternative to the current addiction medication and believes it will be helpful to patients.